Could magnetic pulses boost memory in Alzheimer's? new pilot study aims to find out

NCT ID NCT06597942

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study is testing whether a non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) can safely improve memory in people with mild-to-moderate Alzheimer's disease. The treatment targets the precuneus, a brain region important for memory. Fifty-four participants will receive either active or sham (placebo) stimulation over several sessions, along with memory tests, brain scans, and bloodwork to look for positive changes. The study's main goals are to see if the treatment is feasible and tolerable, and to gather early signs of whether it might help memory.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

repetitive transcranial magnetic stimulation (rTMS) targeting the precuneus

What this could lead to

If it works, this could point toward a non-invasive brain stimulation treatment to help maintain or improve memory in people with Alzheimer's disease.

What could go wrong

This is a small, early-phase pilot study (Phase 1/2) with only 54 participants. Previous rTMS research in Alzheimer's has shown mixed results, and the main goal here is to test feasibility and safety, not to prove effectiveness. Common side effects include headache and scalp discomfort; rare but serious risks include seizure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UCLA TMS Clinical and Research Service

    RECRUITING

    Los Angeles, California, 90095, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact